trapidil has been researched along with Coronary Restenosis in 9 studies
Trapidil: A coronary vasodilator agent.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We hypothesize that the utilization of trapidil-eluting DES in the setting of acute coronary syndromes will be characterized by a greater early re-endothelialization associated with an antiproliferative effect offering a similar efficacy with a better safety profile compared with first-generation DES." | 9.14 | Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e ( Iaccarino, D; Modena, MG; Monopoli, D; Politi, L; Rossi, R; Sangiorgi, GM; Sgura, F, 2010) |
| "We hypothesize that the utilization of trapidil-eluting DES in the setting of acute coronary syndromes will be characterized by a greater early re-endothelialization associated with an antiproliferative effect offering a similar efficacy with a better safety profile compared with first-generation DES." | 5.14 | Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e ( Iaccarino, D; Modena, MG; Monopoli, D; Politi, L; Rossi, R; Sangiorgi, GM; Sgura, F, 2010) |
| "Aspirin was given to all patients, and ticlopidine 250 mg b." | 2.71 | Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. ( Balducelli, M; Barlera, S; Bernardi, G; Latini, R; Maggioni, AP; Maresta, A; Moccetti, T; Monici Preti, A; Ribeiro da Silva, EE; Sosa, C; Varani, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, M | 1 |
| Mhulláin, FN | 1 |
| Nolan, M | 1 |
| Iaccarino, D | 1 |
| Politi, L | 1 |
| Rossi, R | 1 |
| Sgura, F | 1 |
| Monopoli, D | 1 |
| Modena, MG | 1 |
| Sangiorgi, GM | 1 |
| Okamoto, S | 1 |
| Nakano, T | 1 |
| Kitai, T | 1 |
| Ishiwata, S | 1 |
| Yamaguchi, T | 1 |
| Maresta, A | 1 |
| Balducelli, M | 1 |
| Latini, R | 1 |
| Bernardi, G | 1 |
| Moccetti, T | 1 |
| Sosa, C | 1 |
| Barlera, S | 1 |
| Varani, E | 1 |
| Ribeiro da Silva, EE | 1 |
| Monici Preti, A | 1 |
| Maggioni, AP | 1 |
| Douglas, JS | 1 |
| Murphy, JG | 1 |
| Serruys, PW | 1 |
| Foley, DP | 1 |
| Pieper, M | 1 |
| Kleijne, JA | 1 |
| de Feyter, PJ | 1 |
4 reviews available for trapidil and Coronary Restenosis
| Article | Year |
|---|---|
Intrepide; Trapidil eluting stent.
Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; | 2008 |
[Clinical trials of restenosis after PTCA and QOL of patients after PTCA].
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Atherectom | 1994 |
[Prevention of postangioplasty restenosis].
Topics: Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Clinical Trials as Topic; Coated Materials, B | 2003 |
Pharmacologic approaches to restenosis prevention.
Topics: Angioplasty, Balloon, Coronary; Cilostazol; Coated Materials, Biocompatible; Coronary Artery Disease | 2007 |
3 trials available for trapidil and Coronary Restenosis
2 other studies available for trapidil and Coronary Restenosis
| Article | Year |
|---|---|
A monk's prayer: O Lord what is the answer to in-stent restenosis? Commentary on the TRAPIST Study.
Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Cor | 2001 |
[Balloon dilatation plus PDGF antagonist. With this coronary arteries remain patent].
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; H | 2001 |